Genomind, Inc. — Form D/A

Genomind, Inc. of KING OF PRUSSIA, PA, a company, filed a Form D amendment with the SEC on 2021-04-23. The offering totals $21.1M, of which $6.4M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (39)

Showing 25 of 39 people.

NameRoleLocation
John Patrick ChadwickDirectorKing of Prussia, PA
Beth Patrick DozoretzDirectorKing of Prussia, PA
Shelloy Patrick KigerDirectorKing of Prussia, PA
Shawn Patrick O'BrienDirectorKing of Prussia, PA
Theresa Patrick SextonDirectorKing of Prussia, PA
Stephen Patrick HallerExecutive OfficerKing of Prussia, PA
Tom Patrick HessExecutive OfficerKing of Prussia, PA
Shawn Patrick O'BrienExecutive OfficerKing of Prussia, PA
Joseph Patrick AntonDirectorKing of Prussia, PA
Brad Patrick LucasDirectorKing of Prussia, PA
Stephen P HallerExecutive OfficerNorfolk, VA
Thomas P HessExecutive OfficerKing of Prussia, PA
Gloria P NussExecutive OfficerNorfolk, VA
Kip P OlmsteadExecutive OfficerKing of Prussia, PA
Brad P LucasDirectorBoston, MA
Shawn P O'BrienDirectorKing of Prussia, PA
Shawn P O'BrienExecutive OfficerKing of Prussia, PA
Theresa P SextonDirectorNashville, TN
John P ChadwickDirectorNashville, TN
Joseph P AntonDirectorBoston, MA
Joseph E AntonDirectorBoston, MA
Ronald I DozoretzDirectorNorfolk, VA
Ronald I DozoretzExecutive OfficerNorfolk, VA
Ronald I DozoretzPromoterNorfolk, VA
Stephen E HallerExecutive OfficerNorfolk, VA

Other filings by this issuer (16)

Showing 15 of 16 filings.

FiledFormOfferingSold
2020-12-09D$11.2M$4.9M
2020-09-17D/A$21.7M$20.6M
2018-12-06D/A$4.5M$4.5M
2018-10-02D/A$4.0M$2.5M
2018-08-28D/A$3.5M$1.5M
2018-07-13D$3.0M$500K
2017-10-24D/A$13.8M$7.8M
2017-02-14D$6.3M$6.3M
2016-07-15D/A$25.9M$20.9M
2016-04-19D/A$19.9M$17.9M
2016-02-08D/A$19.8M$15.8M
2015-12-28D/A$13.8M$13.8M
2015-11-06D/A$13.3M$12.3M
2015-06-22D/A$12.8M$9.8M
2015-01-30D/A$6.8M$5.3M

More